期刊文献+

BAF-1在重症肌无力患者增生型胸腺组织中的表达

下载PDF
导出
摘要 目的探讨BAF-1与重症肌无力(MG)患者增生型胸腺组织的关系。方法免疫组织化学染色方法分析比较35例正常胸腺组织和35例增生型胸腺组织中BAF-1蛋白的表达状况。结果与正常胸腺组织相比较,MG患者增生型胸腺组织中可见BAF-1阳性表达。结论 BAF-1可能与MG患者增生型胸腺的发生有关。
出处 《中国实用神经疾病杂志》 2014年第10期87-88,共2页 Chinese Journal of Practical Nervous Diseases
基金 河南省医学科技攻关计划项目(编号2011020050)
  • 相关文献

参考文献6

  • 1Reiser H, Stadeeker MJ. Costimulatory B7 molecules in the pathogenesis of infection and autoimmune disease[J]. N Eng J Med, 1996,335 (18): 1 369.
  • 2Cavalcante P,Bernaseoni P,Mantegazza R. Autoimmune mech anisms in myasthenia gravis [J]. Curr Opin Neurol, 2012, 25 (5) :621-629.
  • 3苏艳宾,李倩如,高峰,张清勇,杜英.趋化因子及其受体在重症肌无力患者胸腺组织的异常表达[J].现代免疫学,2011,31(3):248-252. 被引量:4
  • 4李永丽,李立,李静孟,朱利伟,崔新征,方华,杨鲲鹏,张清勇,高峰.重症肌无力患者胸腺增生组织中11000条带的蛋白质组学分析[J].郑州大学学报(医学版),2012,47(3):291-295. 被引量:6
  • 5Furukawa K, Aida T, Nonaka Y, et al. BAF as a caspase de- pendent mediator of nuclear apoptosis in Drosophila [J].J Struct Biol,2007,160(2) : 125-34.
  • 6Gorjandcz M, Klerkx EP, Galy V, et al. Caenorhabditis ele- gans BAF-I and its kinase VRK-I participate directly in post- mitotic nuclear envelope assembly[J]. EMBO J, 2007, 26(1) : 132-143.

二级参考文献20

  • 1唐秀娟,臧敬五.趋化因子系统与中枢神经系统炎症性疾病[J].现代免疫学,2007,27(2):173-176. 被引量:6
  • 2Nagane Y, Utsugisawa K, Ohara D, et al. Dendritic cells in hyperplastic thymuses from patients with myasthenia gravis [J]. Muscle Nerve, 2003,27:582- 589.
  • 3Le Panse R, Bisumuth J, Gizeron Clairac G, et al. Thymic remodeling associated with hyperplasia in myaslhenia gravis [J]. Autoimmunity, 2010,,13:401- 412.
  • 4Onodera H. The role of the thymus in the pathogenesis of myastheniagravis[J].Tohoku J Exp Med. 2005.207:87-98.
  • 5Schwarz BA. Sambandam A, Maillard I, et al. Selective thy mus settling regulated by cytokine and chemokine receptors [J]. J Immunol, 2007,178:2008-2017.
  • 6Scimone ML, Aifantis I, Apostolou I. et al. A multistep ad- hesion cascade for lymphoid progenitor cell homing to the thymus[J]. Proc Natl Acad Sci USA. 2006.103:7006-7011.
  • 7Meraouna A, Cizeron Clairc G, Panse RL. et al. The che- mokine CXCL13 is a key molecule in autoimmune myasthenia gravis[J]. Blood, 2006,108:432-440.
  • 8Le Panse R, Cizeron Clairc G. Bismuth J, et al. Microarrays reveal distinct gene signatures in the thymus of seropositive and seronegative myasthenia gravis patients and the role of CC chemokine ligand 21 in thymic hyperplasia[J]. J Immu- nol, 2006,177:7868- 7879.
  • 9Le Panse R, Cizeron-Clairc G, Cuvelier M, et al. Regulatory and pathogenic mechanisms in human autoimmune myasthe- nia gravis[J]. Ann N Y Acad Sci, 2008,1132:135-142.
  • 10Matsumoto Y, Matsuo H, Sakuma H, et al. CDR3 spectra-- typing analysis of the TCR repertoire in myasthenia gravis [J]. J Immunol, 2006,176:5100-5107.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部